Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis

Published:1995-04-28 Issue:5210 Volume:268 Page:567-569
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Pandey Akhilesh¹,Shao Haining¹,Marks Rory M.²,Polverini Peter J.³,Dixit Vishva M.¹

Affiliation:

1. Department of Pathology, University of Michigan Medical School, Ann Arbor 48109, USA.

2. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Ml 48109, USA.

3. School of Dentistry, University of Michigan, Ann Arbor, Ml 48109, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference17 articles.

1. ARUFFO, A, CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE, CELL 61: 1303 (1990).

2. Baglioni, C., Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine: 425 (1992).

3. BARTLEY, T.D., B61 IS A LIGAND FOR THE ECK RECEPTOR PROTEIN-TYROSINE KINASE, NATURE 368: 558 (1994).

4. FAJARDO, L.F., DUAL ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA IN ANGIOGENESIS, AMERICAN JOURNAL OF PATHOLOGY 140: 539 (1992).

5. Angiogenic Factors

Cited by 339 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products targeting tumour angiogenesis;British Journal of Pharmacology;2023-10-05

2. Targeting Inflammation to Control Tissue Fibrosis;International Journal of Drug Discovery and Pharmacology;2022-12-21

3. The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size;Journal of Biological Chemistry;2022-10

4. The efficacy of EphA2 tyrosine phosphorylation increases with EphA2 oligomer size;2022-06-09

5. EFNA1in gastrointestinal cancer: Expression, regulation and clinical significance;World Journal of Gastrointestinal Oncology;2022-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3